DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED – Trademark Portfolio
Entity Type: 99
DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DROPHIL. The owner is based in Shenzhen.
201, Bldg. 6, Yinxing Life and Health
Tech Park, No.19 Linhui Rd, Kengzi St.
Shenzhen 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED have?
DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED file in?
DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED's most well-known trademarks?
DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED's registered trademark portfolio includes well-known marks such as DROPHIL. These are among 2 currently registered trademarks in the portfolio.
What is DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED's trademark registration success rate?
DROPHIL BIOTECH (SHENZHEN) COMPANY LIMITED has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.